Apiotix Technologies

logo Apiotix

About Us

Apiotix Technologies is a biotech spin-off company from Hedera Ltd., specializing in honey-bee products (supplements and cosmetics) since 1989.

We are dedicated to the R&D of natural products to improve the health of people, animals, plants, and their shared environment. 

Our work is based on more than 15 years of research collaboration with scientific institutions and the industry.

Opportunity

Antimicrobial resistance as global public health emergency

Solution

Non-antibiotic solution, potent antioxidant and immunomodulator for pharmaceutical, cosmetics and food industry

Secret Sauce

Pharmaceutically standardized extraction and purification process of honey bee-based products

Executive Team

Jelena Suran

CEO, Jelena Šuran, DVM, PhD

Jelena worked as an Associate Professor of Pharmacology at Faculty of Veterinary Medicine, University of Zagreb. She has 14 years of experience in pharmacology research, teaching and regulatory affairs. Now she implements her knowledge and passion for science in everyday Apiotix Technologies activities and projects.

jelena@apiotix.eu

Bozo Radic

COO, Božo Radić, MD, PhD

Božo is a medical doctor specializing in gastroenterology. His family founded Hedera, a company specialized in honey bee products and he knows everything about the production, raw material supply, control, and preparation of propolis-based products. He has a Ph.D. in the field of pharmacology, and an extensive experience in animal model studies.

bozo@apiotix.eu

apiotix_cfo_vlado_sliskovic

CFO, Vlado Slišković, M.Fin.

Vlado graduated from the Webster University Vienna, received his M.Fin. in international finances from the EADA Business School Barcelona. He has 15+ years of experience in financial consulting and corporate finance industry.Vlado has entrepreneurial and fund raising experience.

 

vlado@apiotix.eu

Industry

Pharmaceutical industry, cosmetic, agriculture, food

Stage

Revenue, seed

Competitors


Direct competitors: cost effective natural antibiotic alternatives

Indirect competitors: antibiotics